Intra Chemicals And Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.50 Cr
as on 23-10-2024
- Company Age 51 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 169.30 Cr
as on 23-10-2024
- Satisfied Charges ₹ 8.50 Cr
as on 23-10-2024
- Revenue 17.90%
(FY 2023)
- Profit 15.83%
(FY 2023)
- Ebitda 12.38%
(FY 2023)
- Net Worth 45.24%
(FY 2023)
- Total Assets 21.39%
(FY 2023)
About Intra Chemicals And Drugs
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹169.30 Cr. The company has closed loans amounting to ₹8.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Siddharth Gupta, Parul Gupta, and Sunil Sharma serve as directors at the Company.
- CIN/LLPIN
U74899DL1973PTC006641
- Company No.
006641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 1973
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Intra Chemicals And Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Gupta  | Director | 09-Jul-2005 | Current |
| Parul Gupta | Director | 11-Aug-1998 | Current |
| Sunil Sharma | Director | 07-May-2013 | Current |
Financial Performance and Corporate Structure Insights of Intra Chemicals And Drugs.
Intra Chemicals And Drugs Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 17.9% increase. The company also saw a substantial improvement in profitability, with a 15.83% increase in profit. The company's net worth Soared by an impressive increase of 45.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intra Chemicals And Drugs?
In 2023, Intra Chemicals And Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Mgf Automobiles Private LimitedActive 26 years 7 months
Siddharth Gupta and Parul Gupta are mutual person
- Mgf Auto Ventures India Private LimitedActive 15 years 2 months
Siddharth Gupta and Parul Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2009 | ₹169.30 Cr | Open |
Icici Bank Limited Creation Date: 27 Jul 2006 | ₹8.50 Cr | Satisfied |
How Many Employees Work at Intra Chemicals And Drugs?
Unlock and access historical data on people associated with Intra Chemicals And Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intra Chemicals And Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intra Chemicals And Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
